A fixed-term unlisted property fund investing in a world-class integrated pathology diagnostic facility in Australia.
The Fund aims to provide investors with income and long-term capital growth through access to a portfolio of property investments.
Bailador is a Sydney-based investment firm providing growth capital to private companies in the information technology sector.
The Global X S&P Biotech ETF (CURE) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science.
Invest in the top 100 innovation-driven companies on the US market.
The Global X Russell 2000 ETF (RSSL) offers investors exposure to US small-cap equities through the Russell 2000 RIC Capped Index.
An institutional-grade, 16-level CBD office tower in the heart of Adelaide's core corridor. Comprehensively refurbished and completed in 2025 with $10.7 million in CAPEX. Positioned to deliver an average projected cash return of 8% P.A.
Investing in high conviction strategic stakes where there is potential to unlock ‘trapped’ value through an active, private equity style investment approach
The Collective aims to provide Investors with a genuinely diversified portfolio of primarily direct property and Own Unlisted Direct Property Trusts.
